The Chemours Company (CC) Total liabilities 2016–2025
The Chemours Company (CC) total liabilities at each fiscal year-end, per SEC filings.
$7.1BFY2025 · since FY2016: $6.0B → $7.1B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $7.1B | +2.8% |
| FY2024 | $6.9B | -7.7% |
| FY2023 | $7.5B | +15.1% |
| FY2022 | $6.5B | +1.0% |
| FY2021 | $6.5B | +3.2% |
| FY2020 | $6.3B | -4.5% |
| FY2019 | $6.6B | +3.5% |
| FY2018 | $6.3B | -1.3% |
| FY2017 | $6.4B | +7.9% |
| FY2016 | $6.0B | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice